Circumcision for prevention of HIV: new analysis demonstrates cost-effectiveness
A team of researchers who conducted a landmark trial in Orange Farm, South Africa, which concluded that male circumcision can sub stantially reduce the risk of becoming infected with HIV, have now studied the economic aspects of this approach to preventing HIV/AIDS. Their new research, published in PLoS Medicine, suggests that circumcision could reduce the cost of health care in South Africa (and other sub-Saharan Countries), mainly through savings on the cost of HIV treatment.
The researchers carried out a set of calculations, using the results from their major â€˜Orange Farm trialâ€
The overall cost of male circumcision, per HIV infection prevented, is reasonable as compared to the costs of other strategies for prevention of HIV. There would also be implications for HIV prevention programs in other African countries.
1. The ground-breaking Orange Farm study was first published in PLoS Medicine in October 2005. http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0020298 2. Within the last few days, it has been announced that two further trials of circumcision for HIV prevention, conducted by research teams in East Africa, have been stopped early. It became clear that the rate of new HIV infections was much lower in circumcised men, compared with uncircumcised men. It was therefore considered that continuing the trials would be unethical. The full results of the East African tr ials have not yet been published. 3. Researchers do not suggest that being circumcised eliminates the risk of HIV infection. It merely reduces it. Other measures to prevent infection are still essential.
Citation: Kahn JG, Marseille E, Auvert B (2006) Cost-effectiveness of male circumcision for HIV prevention in a South African setting. PLoS Med 3(12): e517.
PLEASE ADD THE LINK TO THE PUBLISHED ARTICLE IN ONLINE VERSIONS OF YOUR REPORT:
PRESS-ONLY PREVIEW OF THE ARTICLE: http://www.plos.org/press/plme-03-12-kahn.pdf
University of California San Francisco
Inst Health Policy Studies
3333 Califor nia Street
San Francisco, California 94118
+1 415-476-0705 (fax)
EMBARGO: MONDAY, 25 December, 5 P.M. PST
PLEASE MENTION THE OPEN-ACCESS JOURNAL PLoS MEDICINE (www.plosmedicine.org) AS THE SOURCE FOR THESE ARTICLES AND PROVIDE A LINK TO THE FREELY-AVAILABLE TEXT. THANK YOU.
All works published in PLoS Medicine are open access. Everything is immediately available without cost to anyone, anywhere to read, download, redistribute, include in databases, and otherwise use subject only to the condition that the original authorship is properly attributed. Copyright is retained by the authors. The Public Library of Science uses the Creative Commons Attribution License.
About PLoS Medicine
PLoS Medicine is an open access, freely available international medical journal. It publishes original research that enhances our understanding of human health and disease, together with commentary and analysis of important global health issues. For more information, visit http://www.plosmedicine.org
About the Public Library of Science
The Public Library of Science (PLoS) is a non-profit organization of scientists and physicians committed to making the world's scientific and medical literature a freely available public resource. For more information, visit http://www.plos.org
Published on PsychCentral.com. All rights reserved.